Carcinoma, Non-Small-Cell Lung
7 competing products in clinical development for Carcinoma, Non-Small-Cell Lung.
Pipeline by Phase
Pre-clinical1
Phase 11
Phase 24
Phase 31
All Products (7)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| 6-Thio-2'-Deoxyguanosine + Cemiplimab + Docetaxel + Vinorelbine + Gemcitabine alone | MAIA Biotechnology | Phase 3 | Recruiting | 69 |
| gemcitabine + carboplatin + cisplatin | Eli Lilly | Phase 2 | Completed | 52 |
| LY2875358 + Erlotinib | Eli Lilly | Phase 2 | Completed | 52 |
| ALIMTA + Carboplatin | Eli Lilly | Phase 2 | Completed | 52 |
| 6-Thio-2'-Deoxyguanosine + Cemiplimab | MAIA Biotechnology | Phase 2 | Recruiting | 44 |
| Cetuximab | Eli Lilly | Phase 1 | Completed | 33 |
| Adjuvant | Insight Molecular Diagnostics | Pre-clinical | Terminated | 15 |